Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 7456 AL 7470

APOE-Targeted Therapeutics for Alzheimer's Disease

Yassine HN, Hugo C, O'Donovan B, Stephens IO, Johnson LA, Cole G, Tcw J, Johansson J, Kisler K, Chiba-Falek O.

J Neurosci. 2025 Nov 12;45(46):e1388252025. doi: 10.1523/JNEUROSCI.1388-25.2025.

Next-generation neurotherapeutics: mechanistic insights on monoclonal antibodies in Alzheimer's disease

Sharma A, Singh TG.

Brain Res. 2026 Jan 1;1870:150047. doi: 10.1016/j.brainres.2025.150047. Epub 2025 Nov 13.

Breaking the Alzheimer's Treatment Stalemate: Synergistic Application Strategies of Nanomaterials and Pharmaceutical Agents

Gao H, Cheng F, Zhang Z, Yan B, Liao P, Zhang S, Li D, Chen F, Lei P.

Mol Neurobiol. 2025 Nov 20;63(1):107. doi: 10.1007/s12035-025-05320-7.

Recent development in PDE4D-targeted inhibitors for Alzheimer's disease therapy

Sun T, Li Z, Xiao B, Yang J, Han M, Zhang J, Liu S, Ma J, Sang Z, Wang P.

Eur J Med Chem. 2026 Jan 15;302(Pt 3):118383. doi: 10.1016/j.ejmech.2025.118383. Epub 2025 Nov 17.

From genes to lifestyle: A multi-dimensional framework for Alzheimer's disease prevention and therapy

Su L, Wang Y.

Ageing Res Rev. 2026 Jan;113:102947. doi: 10.1016/j.arr.2025.102947. Epub 2025 Nov 19.

Therapeutic promise of α-hederin in Alzheimer's disease: Insights into inflammation, oxidative stress, and apoptosis modulation

Chettupalli AK, Gupta N, Bukke SPN, Singh MP, Mandal C.

Biomed Pharmacother. 2025 Dec;193:118803. doi: 10.1016/j.biopha.2025.118803. Epub 2025 Nov 22.

The Role of Bacopa monnieri in Alzheimer's Disease: Mechanisms and Potential Clinical Use-A Review

Wiciński M, Fajkiel-Madajczyk A, Wójcicki J, Ozorowski M, Szambelan M.

Nutrients. 2025 Nov 12;17(22):3538. doi: 10.3390/nu17223538.

Transforming anti-Alzheimer's therapy by targeting endogenous receptorrial system through ligand-conjugated nanoformulations

Gawai M, Nistane N, Tatode AA, Qutub M, Umekar MJ, Premchandani T, Taksande JB.

Ageing Res Rev. 2026 Jan;114:102994. doi: 10.1016/j.arr.2025.102994. Epub 2025 Dec 13.

Targeting brain connectivity in Alzheimer's disease with repurposed drugs

Pini L, Imbimbo BP, Griffa A, Allali G, Pomara N.

Ageing Res Rev. 2026 Jan;114:103001. doi: 10.1016/j.arr.2025.103001. Epub 2025 Dec 18.

Protein and peptide based nanotherapeutics for the management of Alzheimer's disease: Current insights and future directions

Das SK, Bashir B, Kolekar KA, Harish V, Patle D, Vishwas S, Mittal N, Jha SK, Kumar P, Gupta G, Dureja H, Dua K, Chang D, Kuppusamy G, Singh SK.

Ageing Res Rev. 2026 Jan;114:103000. doi: 10.1016/j.arr.2025.103000. Epub 2025 Dec 18.

PACAP: A promising disease-modifying target for Alzheimer's disease

Basri R, Al-Kuraishy HM, Fawzy MN, Alruwaili M, Batiha GE.

Life Sci. 2026 Feb 1;386:124176. doi: 10.1016/j.lfs.2025.124176. Epub 2025 Dec 24.

Emerging therapeutics targeting the PI3K/Akt/GSK-3β in calcium dysregulation in Alzheimer's disease

Soni S, Kaur G.

Cell Calcium. 2026 Jan;133:103107. doi: 10.1016/j.ceca.2025.103107. Epub 2025 Dec 23.

Metal-Organic Frameworks as Interfacial Platforms for Early Diagnosis of Alzheimer's Disease

Thokal G, Garg M, Bathinapatla A, Farale H, Kanchi S.

Langmuir. 2026 Jan 13;42(1):32-56. doi: 10.1021/acs.langmuir.5c04804. Epub 2025 Dec 29.

Precision therapeutic strategies for Alzheimer's disease: Amyloid β-targeted foundations and multimodal next-generation approaches

Zafar I, Khan MS, Jamal A, Shafiq S, Bahwerth FS, Khan NU.

Mol Cell Neurosci. 2026 Mar;136:104070. doi: 10.1016/j.mcn.2025.104070. Epub 2025 Dec 30.

Therapeutic Applications of Natural Flavonoids Against Alzheimer's Disease-like Pathology: Special Focus on PI3K/Akt and Nrf2 Signaling Pathways

Singh NK, Varshney N.

Curr Neurovasc Res. 2025;22(4):276-295. doi: 10.2174/0115672026423088251205120807.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias